Technology | Quality Assurance (QA) | November 24, 2015

CIRS Displays Prototype CT Angiography Phantom to Test Motion Artifacts

Human thorax phantom mimics translation, rotational motion of the heart

CIRS, Dynamic Cardiac Phantom, CT, RSNA 2015

Image courtesy of CIRS Inc.

November 24, 2015 — The Dynamic Cardiac Phantom is a precision instrument which mimics the translation and rotational motion of the heart in a tissue-equivalent phantom. It is designed for comprehensive analysis of image quality, calcification detection and iodine contrast detection. The phantom represents an average human thorax in shape, proportion and composition. A Plastic Water DT rod containing a solid, anatomically-shaped heart model is inserted into the mediastinum of the phantom. The heart model contains cavities representing the coronary arteries, which can be replaced with targets of different calcification or iodine contrast levels depending on the required application. The body is connected to a motion actuator box that induces motion through linear translation and rotation of the Plastic Water DT rod. Motion of the rod itself is radiographically invisible due to its matching density with the surrounding material. Both the heart and the targets, given their density difference, can be resolved.

The phantom is controlled using CIRS Motion Control Software and includes a motion profile of an average beating heart and matching electrocardiogram (ECG) signal at 60 bpm. Through the intuitive user interface, users can adjust amplitudes and heart rate, or import patient-specific cardiac motion profiles.

For more information: www.cirsinc.com

Related Content

National Cancer Institute Grant Creates National Lung Cancer Screening Center
News | Lung Cancer | April 23, 2018
Researchers from the Perelman School of Medicine at the University of Pennsylvania and four other institutions have...
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Somatom go.All and Somatom go.Top computed tomography (CT)...
Canon Medical Systems' Aquilion Precision CT Receives FDA Clearance
Technology | Computed Tomography (CT) | April 13, 2018
April 13, 2018 — Canon Medical Systems USA Inc. this week received U.S.
Brainomix Secures $9.8m Investment to Tackle Strokes With AI
News | Stroke | April 05, 2018
April 5, 2018 — Medical imaging company Brainomix has attracted £7m ($9.8 million) of investment to bring its...
FDA Clears Siemens Somatom Edge Plus CT System
Technology | Computed Tomography (CT) | April 04, 2018
April 4, 2018 — The U.S.
Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp.
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
Overlay Init